New approaches to the systemic treatment of melanoma

This publication has 41 references indexed in Scilit:

• Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-α
  Annals of Oncology, 1996
• Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
  Nature Medicine, 1995
• Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen
  European Journal Of Cancer, 1995
• Fotemustine
  Melanoma Research, 1992
• Treatment of Metastatic Malignant Melanoma with Dacarbazine plus Tamoxifen
  New England Journal of Medicine, 1992
• Interferon α-2a and Dacarbazine in Melanoma
  JNCI Journal of the National Cancer Institute, 1990
• Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapy
  Cancer Treatment Reviews, 1988
• A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous Melanoma
  New England Journal of Medicine, 1982
• Human models of human diseases; breast cancer and the lymphomas
  International Journal of Radiation Oncology*Biology*Physics, 1979
• PRELIMINARY RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT IMMUNOTHERAPY IN PATIENTS WITH MALIGNANT MELANOMA WHO HAVE LYMPH NODE METASTASES
  Anz Journal of Surgery, 1978